Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes

E-ISSN： 1875-6182|5|3|236-240

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.5, Iss.3, 2007-07, pp. : 236-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products and Cardiovascular Disease

Current Diabetes Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 92-100

Bentham Science Publishers

Access to resources Recommend Favorite

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

Recent Patents on Cardiovascular Drug Discovery, Vol. 10, Iss. 1, 2015-04 ,pp. : 10-33

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications

Current Diabetes Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-106

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products: A Link Between Periodontitis and Diabetes Mellitus?

Current Diabetes Reviews, Vol. 9, Iss. 5, 2013-09 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

By Tan K. Shiu S. Chow W. Leng L. Bucala R. Betteridge D.

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2756-2762

Springer Publishing Company

Access to resources Recommend Favorite